Functional neurological disorders after COVID-19 and SARS-CoV-2 vaccines: a national multicentre observational study

被引：8

作者：

Alonso-Canovas, Araceli ^{[1
,2
]}

Kurtis, Monica M. ^{[3
]}

Gomez-Mayordomo, Victor ^{[4
]}

Macias-Garcia, Daniel ^{[5
,6
]}

Viedma, Alvaro Gutierrez ^{[7
]}

Rezola, Elisabet Mondragon ^{[8
]}

Pagonabarraga, Javier ^{[9
,10
]}

Orgaz, Lidia Aranzabal ^{[11
]}

Masjuan, Jaime ^{[1
,2
]}

Martinez-Castrillo, Juan Carlos ^{[1
,2
]}

Parees, Isabel ^{[2
,3
]}

机构：

[1] Univ Alcala, Med Dept, Madrid, Spain

[2] Hosp Univ Ramon & Cajal, Neurol Dept, Movement Disorders Unit, IRYCIS, Madrid, Spain

[3] Hosp Ruber Int, Neurol Dept, Funct Movement Disorders Unit, Madrid, Spain

[4] Vithas Hosp Grp, Inst Neurosci, Dept Neurol, Madrid, Spain

[5] CIBERNED, Madrid, Spain

[6] Univ Seville, Hosp Univ Virgen Rocio, Neurol & Neurophysiol Dept, Movement Disorders Unit,Inst Biomed Sevilla,CSIC, Seville, Spain

[7] Hosp Univ Fdn Jimenez Diaz, Neurol Dept, Funct Disorders Unit, Madrid, Spain

[8] Hosp Univ Donostia, Dept Neurol, Inst Invest Sanitaria Biodonostia, San Sebastian, Spain

[9] Univ Autonoma Barcelona UAB, Hosp St Pau, Neurol Dept, Movement Disorders Unit, Barcelona, Spain

[10] St Pau Inst Biomed Res IIB St Pau, Barcelona, Spain

[11] Hosp Univ Ramon & Cajal, Internal Med Dept, Madrid, Spain

来源：

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY | 2023年 / 94卷 / 09期

关键词：

COVID-19; CONVERSION DISORDER; FUNCTIONAL NEUROLOGICAL DISORDER;

D O I：

10.1136/jnnp-2022-330885

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：776 / 777

页数：2

共 50 条

[1] SARS-CoV-2 mediated neuroinflammation and the impact of COVID-19 in neurological disorders
Amruta, Narayanappa
Chastain, Wesley H.
Paz, Meshi
Solch, Rebecca J.
Murray-Brown, Isabel C.
Befeler, Jaime B.
Gressett, Timothy E.
Longo, Michele T.
Engler-Chiurazzi, Elizabeth B.
Bix, Gregory
CYTOKINE & GROWTH FACTOR REVIEWS, 2021, 58 : 1 - 15
[2] Role of COVID-19 Vaccines in SARS-CoV-2 Variants
Zhou, Zhou
Zhu, Yimiao
Chu, Ming
FRONTIERS IN IMMUNOLOGY, 2022, 13
[3] COVID-19 vaccines and decreased transmission of SARS-CoV-2
A. Vitiello
F. Ferrara
V. Troiano
R. La Porta
Inflammopharmacology, 2021, 29 : 1357 - 1360
[4] COVID-19 vaccines and decreased transmission of SARS-CoV-2
Vitiello, A.
Ferrara, F.
Troiano, V
La Porta, R.
INFLAMMOPHARMACOLOGY, 2021, 29 (05) : 1357 - 1360
[5] Neurological Manifestations of COVID-19 (SARS-CoV-2): A Review
Ahmed, Muhammad Umer
Hanif, Muhammad
Ali, Mukarram Jamat
Haider, Muhammad Adnan
Kherani, Danish
Memon, Gul Muhammad
Karim, Amin H.
Satter, Abdul
FRONTIERS IN NEUROLOGY, 2020, 11
[6] SARS-CoV-2 mediated neurological disorders in COVID-19: Measuring the pathophysiology and immune response
Hsu, Pi -Ching
Shahed-Al-Mahmud, Md.
LIFE SCIENCES, 2022, 308
[7] SARS-CoV-2/COVID-19 and Hypertensive Pregnancy Disorders: Evaluation of the CRONOS National Registry
Zoellkau, Janine
Bohlmann, Michael
Mingers, Nina
Pecks, Ulrich
Weschenfelder, Friederike
Groten, Tanja
ZEITSCHRIFT FUR GEBURTSHILFE UND NEONATOLOGIE, 2023, 227 (02): : 120 - 126
[8] Neurological Complications of SARS-CoV-2 Infection and COVID-19 Vaccines: From Molecular Mechanisms to Clinical Manifestations
Yepes, Manuel
CURRENT DRUG TARGETS, 2022, 23 (17) : 1620 - 1638
[9] Insights into the immune responses of SARS-CoV-2 in relation to COVID-19 vaccines
Heedo Park
Mee Sook Park
Jong Hyeon Seok
Jaehwan You
Jineui Kim
Jeonghun Kim
Man-Seong Park
Journal of Microbiology, 2022, 60 : 308 - 320
[10] Update on the effectiveness of COVID-19 vaccines on different variants of SARS-CoV-2
Firouzabadi, Negar
Ghasemiyeh, Parisa
Moradishooli, Fatemeh
Mohammadi-Samani, Soliman
INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 117

← 1 2 3 4 5 →